(1 - 6 von 7
)
Un Nuevo Estudio Demuestra que el uso de Xeloda Aumenta ...
www.europapress.es
— Stefan Manth, Director Comercial de Oncología de Roche manifestó que "los resultados de esta prueba ofrecen nuevas esperanzas a los ... › notici...
EC approves Bondronat for breast cancer, bone metastases
test.pharmabiz.com
... efficacy and a much improved safety profile compared with currently available i.v. bisphophonates," said Dr Stefan Manth, director of Oncology at Roche. › news
TUMORE DEL COLON-RETTO: LA CAPECITABINA RIDUCE ...
www.medinews.it
Secondo Stefan Manth, Business Director in Oncologia di Roche, “i risultati di questo studio offrono nuove speranze ai pazienti e alle loro famiglie. › congressi
Bondronat for treatment of Metastatic Bone Disease Clears
www.globenewswire.com
— ... bisphosphonates currently in use for the treatment of metastatic bone disease," said Dr Stefan Manth, Director of Oncology at Roche. › ...
sortiert nach Relevanz / Datum